Investor Relations

SEC Filings

Form 10-Q
VANDA PHARMACEUTICALS INC. filed this Form 10-Q on 11/07/2018
Document Outline
Entire Document (3450.6 KB)
Subdocument 1 - 10-Q - 10-Q
Page 1 - UNITED STATES
Page 2 - Vanda Pharmaceuticals Inc.
Page 3 - CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
Page 4 - Part I FINANCIAL INFORMATION
Page 5 - VANDA PHARMACEUTICALS INC.
Page 6 - VANDA PHARMACEUTICALS INC.
Page 7 - VANDA PHARMACEUTICALS INC.
Page 8 - VANDA PHARMACEUTICALS INC.
Page 9 - VANDA PHARMACEUTICALS INC.
Page 10 - Revenue Recognition
Page 11 - Chargebacks:
Page 12 - Statement of Cash Flows Classification of Certain Cash Receipts and Cash Payments
Page 13 - 3. Marketable Securities
Page 14 - 5. Inventory
Page 15 - Fanapt
Page 16 - 7. Accounts Payable and Accrued Liabilities
Page 17 - License Agreements
Page 18 - VQW-765.
Page 19 - Stock Options
Page 20 - Stock-Based Compensation
Page 21 - 13. Earnings per Share
Page 22 - Approved Drug Products with Therapeutic Equivalence Evaluations
Page 23 - N/A
Page 24 - Overview
Page 25 - Risk Factors
Page 26 - Prompt-pay:
Page 27 - Stock-based compensation
Page 28 - Recent Accounting Pronouncements
Page 29 - Selling, general and administrative expenses.
Page 30 - Cost of goods sold.
Page 31 - Selling, general and administrative expenses.
Page 32 - Cash Flow
Page 33 - Contractual Obligations and Commitments
Page 34 - Foreign currency risk
Page 35 - Approved Drug Products with Therapeutic Equivalence Evaluations
Page 36 - Risk Factors
Page 37 - N/A
Page 38 - SIGNATURES
Subdocument 2 - EX-10.41 - EX-10.41
Page 1 - EXHIBIT 10.41
Page 2 - 2.Cash and Incentive Compensation.
Page 3 - Restricted Stock Units
Page 4 - Rights Upon Termination
Page 5 - Target Bonus
Page 6 - Change in Control
Page 7 - Code
Page 8 - Tax Matters
Page 9 - IN WITNESS WHEREOF
Subdocument 3 - EX-31.1 - EX-31.1
Page 1 - N/A
Subdocument 4 - EX-31.2 - EX-31.2
Page 1 - N/A
Subdocument 5 - EX-32.1 - EX-32.1
Page 1 - N/A
Subdocument - EX-101.INS - XBRL INSTANCE DOCUMENT
Subdocument - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
Subdocument - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
Subdocument - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
Subdocument - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
Subdocument - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
Subdocument - XBRL Viewer
  
Home | About Vanda | Product Pipeline| Partnering | Investor Relations | News | Careers | Contact Us
Copyright © 2005-2019 Vanda Pharmaceuticals | Terms & Conditions | Privacy Policy